Tanshinone II-A: new perspectives for old remedies

Bibliography

• Gao S, Liu Z, Li H, Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis 2012;220(1):3-10
   PubMed Web of Science ®Google Scholar
• Zhou L, Zuo Z, Chow MS. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005;45(12):1345-59
   PubMed Web of Science ®Google Scholar
• Wang J, Lu W, Chen Y, Application of tanshinone IIA or pharmaceutically acceptable salts thereof in preparing medicines for treating or preventing pulmonary hypertension disease. CN102160866; 2011
   Google Scholar
• Shang Q, Xu H, Huang L. Tanshinone IIA: a promising natural cardioprotective agent. Evid Based Complement Alternat Med 2012;2012:716459
   Google Scholar
• Taehwan K, Myunggyu P. Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity. US8029832; 2011
   Google Scholar
• Jia Y, Huang F, Zhang S, Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbide dinitrate in treating angina pectoris? A systematic review of randomized controlled trials. Int J Cardiol 2012;157(3):330-40
   Web of Science ®Google Scholar
• Lee KH, Wang X, Bastow K, Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents. US7795299 B2; 2010
   Google Scholar
• Gu L, Liu P, Li G, Tanshinone IIA for prophylaxising or treating atherosclerosis. WO2004058245; 2004
   Google Scholar
• Kwak TH, Park MG. Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity. KR20080015495; 2008
   Google Scholar
• Tang F, Wu X, Wang T, Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. Vascul Pharmacol 2007;46(6):427-38
   PubMed Web of Science ®Google Scholar
• Tang FT, Cao Y, Wang TQ, Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression. Eur J Pharmacol 2011;650(1):275-84
   PubMed Web of Science ®Google Scholar
• Xu S, Little PJ, Lan T, Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet. Arch Biochem Biophys 2011;515(1-2):72-9
   Google Scholar
• Xu S, Liu Z, Huang Y, Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-kappaB activation. Transl Res 2012;160(2):114-24
   Google Scholar
• Chen W, Tang F, Xie B, Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress. Eur J Pharmacol 2012;674(2-3):359-64
   PubMed Web of Science ®Google Scholar
• Fang J, Xu SW, Wang P, Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension. Phytomedicine 2010;18(1):58-64
   Google Scholar
• Wang P, Wu X, Bao Y, Tanshinone IIA prevents cardiac remodeling through attenuating NAD(P)H oxidase-derived reactive oxygen species production in hypertensive rats. Pharmazie 2011;66(7):517-24
   PubMed Web of Science ®Google Scholar
• Fu J, Huang H, Liu J, Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol 2007;568(1-3):213-21
   PubMed Web of Science ®Google Scholar
• Gao J, Yang G, Pi R, Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis. Transl Res 2008;151(2):79-87
   Google Scholar
• Xu S, Ogura S, Chen J, LOX-1 in Atherosclerosis: biological Functions and Pharmacological Modifiers. Cell Mol Life Sci 2012; DOI: 10.1007/s00018-012-1194-z
   Google Scholar
• Dong Y, Morris-Natschke SL, Lee KH. Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents. Nat Prod Rep 2011;28(3):529-42
   PubMed Web of Science ®Google Scholar
• Gong Z, Huang C, Sheng X, The role of tanshinone IIA in the treatment of obesity through peroxisome proliferator-activated receptor gamma antagonism. Endocrinology 2009;150(1):104-13
   Google Scholar
• Fang ZY, Lin R, Yuan BX, Tanshinone IIA inhibits atherosclerotic plaque formation by down-regulating MMP-2 and MMP-9 expression in rabbits fed a high-fat diet. Life Sci 2007;81(17-18):1339-45
   Google Scholar
• Chen Y, Wu X, Yu S, Neuroprotection of tanshinone IIA against cerebral ischemia/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats. PLoS One 2012;7(6):e40165
   Web of Science ®Google Scholar
• Li YS, Wang ZH, Wang J. Effect of tanshinone II A on angiotensin receptor in hypertrophic myocardium of rats with pressure over-loading. Zhongguo Zhong Xi Yi Jie He Za Zhi 2008;28(7):632-6
   Google Scholar
• Yu XY, Lin SG, Zhou ZW, Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge. Curr Drug Metab 2007;8(4):325-40
   PubMed Web of Science ®Google Scholar
• Zhang W, He H, Liu J, Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins. Biomaterials 2013;34(1):306-19
   PubMed Web of Science ®Google Scholar
• Tillhon M, Guaman Ortiz LM, Lombardi P, Berberine: new perspectives for old remedies. Biochem Pharmacol 2012;84(10):1260-7
   PubMed Web of Science ®Google Scholar
• Zhu B, Zhai Q, Yu B. Tanshinone IIA protects rat primary hepatocytes against carbon tetrachloride toxicity via inhibiting mitochondria permeability transition. Pharm Biol 2010;48(5):484-7
   PubMed Web of Science ®Google Scholar
• Xu JK, Hiroshi K, Zheng JJ, Protective effect of tanshinones against liver injury in mice loaded with restraint stress. Yao Xue Xue Bao 2006;41(7):631-5
   Google Scholar
• Xu W, Ren X, Tang L, Composition containing tanshinone ingredient and HMG-CoA reductase inhibitor and application thereof. CN101596317; 2008
   Google Scholar
• Liu P, Gu L, Xu S. Medicinal composition for preventing and treating atherosclerosis. CN102125567; 2011
   Google Scholar
• Chan P, Liu IM, Li YX, Antihypertension induced by tanshinone IIA isolated from the roots of salvia miltiorrhiza. Evid Based Complement Alternat Med 2011;2011:392627
   PubMed Web of Science ®Google Scholar
• Li Y, Yang Y, Yu D, The effect of tanshinone IIA upon the TGF-beta1/Smads signaling pathway in hypertrophic myocardium of hypertensive rats. J Huazhong Univ Sci Technolog Med Sci 2009;29(4):476-80
   Google Scholar
• Su CC. Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II. Exp Ther Med 2012;3(3):555-9
   Web of Science ®Google Scholar
• Wang W, Liu E. Medicinal composition of tanshinone IIA sulfate and ferulic acid and preparation method thereof. CN1806799; 2006
   Google Scholar